AMT MDT Certification Sample Questions

The AMT Molecular Diagnostics Technologist Certification Sample Question Set on this page is designed to familiarize you with the actual AMT MDT exam format and question types. These sample questions help you understand how questions are structured and what to expect on test day. While they provide a useful starting point, they represent only a limited preview of the real exam experience.

These sample questions are intended for evaluation and familiarization only. To understand exam style, pacing, and reasoning patterns more clearly, we recommend trying our online sample practice environment. If you are preparing for the AMT Molecular Diagnostics Technologist (MDT) and want to assess your readiness more rigorously, structured, timed, scenario-based practice is recommended. This approach aligns with the cognitive demands and professional expectations typically associated with Molecular diagnostics technologists, medical laboratory scientists, clinical laboratory professionals and related roles working in settings such as Clinical laboratory, research setting, industrial molecular diagnostics setting.

Try Sample Exam »    |    Access Full AMT MDT Practice Exam »

The demo introduces core concepts, while full-length premium simulations provide deeper, scenario-based coverage that more closely reflects the actual cognitive demands of the AMT Molecular Diagnostics Technologist exam, particularly in areas such as Molecular diagnostic methods, molecular laboratory procedures, laboratory quality and safety. You can use these sample questions as a starting point, then progress to the AMT MDT Certification Practice Exam for stronger readiness. Our premium simulations are designed to mirror real exam conditions, helping you refine reasoning, pacing, and decision-making before your official exam attempt.

AMT MDT Sample Questions:

01. A capillary electrophoresis fragment analysis run shows a very strong peak in one dye channel. A smaller peak appears at the same size in another dye channel, and the instrument software flags possible spectral pull-up.
Which interpretation is most appropriate?
a) The smaller peak may be an artifact from spectral overlap and should be reviewed according to assay criteria
b) Spectral pull-up proves that both peaks are true independent alleles
c) Dye-channel artifacts are impossible in capillary electrophoresis
d) The smaller peak should be reported without review because software flags are never relevant

02. A high-positive specimen is diluted 1:10, 1:100, and 1:1,000 during quantitative assay validation. The measured results do not decrease proportionally with dilution at the highest concentration, suggesting signal saturation.
Which concept is being evaluated?
a) PPE selection for splash risk
b) Linearity and reportable range
c) Autosomal recessive phase
d) FISH nuclear truncation

03. A laboratory validates a new molecular assay by testing patient specimens previously characterized by a well-established comparator method. The laboratory evaluates whether the new assay results agree with the comparator.
Which performance characteristic is primarily being assessed?
a) Accuracy or method agreement
b) Eyewash accessibility
c) SDS hazard classification
d) Codon wobble

04. A Molecular Diagnostics Technologist receives extracted RNA that was left at room temperature for 5 hours after extraction. The laboratory procedure states that extracted RNA must be placed on ice during short handling periods and stored at −70°C if testing is delayed beyond 1 hour. The technologist notes that the specimen container is correctly labeled and the extraction control from the original run was acceptable.
Which action is most appropriate?
a) Reject or recollect the specimen according to procedure because RNA stability requirements were exceeded
b) Freeze the RNA now and report the result with no comment because the label is correct
c) Dilute the RNA before amplification to compensate for possible degradation
d) Proceed with testing because the extraction control was acceptable at the time of extraction

05. A molecular laboratory generates used extraction tubes containing residual guanidinium-based lysis buffer and biological specimen material. A technologist places the tubes into a regular trash container because the tubes are capped and no liquid is visible externally.
Which action is most appropriate?
a) Dispose of the waste according to laboratory procedures for chemical and biohazardous waste
b) Use regular trash because capped tubes are never hazardous
c) Rinse the tubes in the sink and then discard them in regular trash
d) Store the tubes indefinitely in the clean reagent freezer

06. A patient specimen produces no target amplification and a delayed internal control, suggesting inhibition. The procedure allows repeat testing after a validated dilution step to reduce inhibitors.
Which outcome would most support inhibition as the original problem?
a) The diluted specimen has no internal-control amplification and no target signal again
b) The diluted specimen shows acceptable internal-control amplification with interpretable target testing
c) The no-template control becomes positive after patient dilution
d) The positive control fails only after the patient specimen is removed from the run

07. A swab specimen for a molecular respiratory assay arrives in a transport medium not listed in the assay’s validated specimen requirements. The specimen is labeled correctly and arrived within the acceptable transport time.
Which action is most appropriate?
a) Follow the laboratory procedure for unvalidated transport medium before testing or reporting
b) Test the specimen automatically because transport time and labeling are acceptable
c) Add validated transport medium to the original tube and proceed without documentation
d) Report the specimen as positive because unvalidated medium increases target concentration

08. A technologist prints a molecular assay procedure and keeps it at the bench for convenience. Three months later, the electronic controlled procedure is revised to change specimen rejection criteria, but the printed copy remains at the bench and is used during accession review.
Which quality concern is most important?
a) Printed procedures are always more accurate than electronic controlled procedures
b) Procedure version does not matter if the assay name is unchanged
c) An uncontrolled outdated procedure may lead staff to apply incorrect acceptance criteria
d) Outdated procedures are acceptable if only one technologist uses them

09. An NGS pipeline annotates a variant using transcript A, but the laboratory report template and validated interpretation workflow use transcript B. The amino acid numbering differs between transcripts.
Which action is most appropriate?
a) Reconcile the annotation to the validated transcript before final interpretation and reporting
b) Report both amino acid positions without explaining which transcript was used
c) Ignore transcript differences because amino acid numbering is always identical
d) Convert the annotation into a FISH signal count

10. Two specimens with similar patient names are processed side by side for DNA extraction. The technologist prints aliquot labels after opening both primary tubes and places unlabeled aliquot tubes in the rack temporarily.
Which workflow change most directly reduces misidentification risk?
a) Rely on tube position only because similar names do not affect molecular testing
b) Label aliquot tubes before transfer and process one specimen at a time according to identification procedure
c) Label aliquots after extraction because DNA is easier to identify than primary specimens
d) Use unlabeled aliquots if the technologist remembers the rack order

Answers:

For full-length, timed, scenario-based practice aligned with the official exam framework - and to build pacing, consistency, and confidence - explore our Premium AMT MDT Certification Practice Exam.

Note: These sample questions are not official exam questions and are intended only for familiarization and study purposes. If you find any typos or data entry errors in these AMT Molecular Diagnostics Technologist (MDT) sample questions, please let us know by emailing us at feedback@medicoexam.com